150 related articles for article (PubMed ID: 34479769)
21. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
22. Does Cancer Literature Reflect Multidisciplinary Practice? A Systematic Review of Oncology Studies in the Medical Literature Over a 20-Year Period.
Holliday EB; Ahmed AA; Yoo SK; Jagsi R; Hoffman KE
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):721-31. PubMed ID: 26104927
[TBL] [Abstract][Full Text] [Related]
23. Differences in Funding Sources of Phase III Oncology Clinical Trials by Treatment Modality and Cancer Type.
Jairam V; Yu JB; Aneja S; Wilson LD; Lloyd S
Am J Clin Oncol; 2017 Jun; 40(3):312-317. PubMed ID: 25374144
[TBL] [Abstract][Full Text] [Related]
24. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study.
Turner K; Carboni-Jiménez A; Benea C; Elder K; Levis B; Boruff J; Roseman M; Bero L; Lexchin J; Turner EH; Benedetti A; Thombs BD
BMJ Open; 2020 May; 10(5):e035633. PubMed ID: 32398334
[TBL] [Abstract][Full Text] [Related]
25. The influence of industry sponsorship on the reporting of subgroup analyses within phase III randomised controlled trials in gastrointestinal oncology.
Barton S; Peckitt C; Sclafani F; Cunningham D; Chau I
Eur J Cancer; 2015 Dec; 51(18):2732-9. PubMed ID: 26608121
[TBL] [Abstract][Full Text] [Related]
26. Outcome reporting among drug trials registered in ClinicalTrials.gov.
Bourgeois FT; Murthy S; Mandl KD
Ann Intern Med; 2010 Aug; 153(3):158-66. PubMed ID: 20679560
[TBL] [Abstract][Full Text] [Related]
27. Factors Associated With Age Disparities Among Cancer Clinical Trial Participants.
Ludmir EB; Mainwaring W; Lin TA; Miller AB; Jethanandani A; Espinoza AF; Mandel JJ; Lin SH; Smith BD; Smith GL; VanderWalde NA; Minsky BD; Koong AC; Stinchcombe TE; Jagsi R; Gomez DR; Thomas CR; Fuller CD
JAMA Oncol; 2019 Dec; 5(12):1769-1773. PubMed ID: 31158272
[TBL] [Abstract][Full Text] [Related]
28. Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis.
Catalá-López F; Aleixandre-Benavent R; Caulley L; Hutton B; Tabarés-Seisdedos R; Moher D; Alonso-Arroyo A
Trials; 2020 Jan; 21(1):34. PubMed ID: 31910857
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others.
Bero L; Oostvogel F; Bacchetti P; Lee K
PLoS Med; 2007 Jun; 4(6):e184. PubMed ID: 17550302
[TBL] [Abstract][Full Text] [Related]
30. Randomized controlled trials in the era of molecular oncology: methodology, biomarkers, and end points.
Kay A; Higgins J; Day AG; Meyer RM; Booth CM
Ann Oncol; 2012 Jun; 23(6):1646-51. PubMed ID: 22048151
[TBL] [Abstract][Full Text] [Related]
31. Association between trial registration and positive study findings: cross sectional study (Epidemiological Study of Randomized Trials-ESORT).
Odutayo A; Emdin CA; Hsiao AJ; Shakir M; Copsey B; Dutton S; Chiocchia V; Schlussel M; Dutton P; Roberts C; Altman DG; Hopewell S
BMJ; 2017 Mar; 356():j917. PubMed ID: 28292744
[No Abstract] [Full Text] [Related]
32. [The Impact of Industrial Sponsorship on Research Findings in Randomised Clinical Trials in Plastic and Aesthetic Surgery: a Cross- Section Analysis of the Past 12 Years].
Alawi SA; Grigorescu O; Bota O; Dragu A
Handchir Mikrochir Plast Chir; 2023 Apr; 55(2):132-139. PubMed ID: 36758580
[TBL] [Abstract][Full Text] [Related]
33. What do letters to the editor publish about randomized controlled trials? A cross-sectional study.
Kastner M; Menon A; Straus SE; Laupacis A
BMC Res Notes; 2013 Oct; 6():414. PubMed ID: 24124753
[TBL] [Abstract][Full Text] [Related]
34. Randomized trials stopped early for benefit: a systematic review.
Montori VM; Devereaux PJ; Adhikari NK; Burns KE; Eggert CH; Briel M; Lacchetti C; Leung TW; Darling E; Bryant DM; Bucher HC; Schünemann HJ; Meade MO; Cook DJ; Erwin PJ; Sood A; Sood R; Lo B; Thompson CA; Zhou Q; Mills E; Guyatt GH
JAMA; 2005 Nov; 294(17):2203-9. PubMed ID: 16264162
[TBL] [Abstract][Full Text] [Related]
35. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.
Bhandari M; Busse JW; Jackowski D; Montori VM; Schünemann H; Sprague S; Mears D; Schemitsch EH; Heels-Ansdell D; Devereaux PJ
CMAJ; 2004 Feb; 170(4):477-80. PubMed ID: 14970094
[TBL] [Abstract][Full Text] [Related]
36. Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005.
Zwierzyna M; Davies M; Hingorani AD; Hunter J
BMJ; 2018 Jun; 361():k2130. PubMed ID: 29875212
[TBL] [Abstract][Full Text] [Related]
37. Reporting Quality of Randomized Controlled Trials of Periodontal Diseases in Journal Abstracts-A Cross-sectional Survey and Bibliometric Analysis.
Kumar S; Mohammad H; Vora H; Kar K
J Evid Based Dent Pract; 2018 Jun; 18(2):130-141.e22. PubMed ID: 29747793
[TBL] [Abstract][Full Text] [Related]
38. Quality of the supportive and palliative oncology literature: a focused analysis on randomized controlled trials.
Hui D; Arthur J; Dalal S; Bruera E
Support Care Cancer; 2012 Aug; 20(8):1779-85. PubMed ID: 21935717
[TBL] [Abstract][Full Text] [Related]
39. Association between industry support and the reporting of study outcomes in randomized clinical trials of dental implant research from the past 20 years.
Dini C; Pereira MMA; Souza JGS; Shibli JA; de Avila ED; Barão VAR
Clin Implant Dent Relat Res; 2022 Feb; 24(1):94-104. PubMed ID: 35019213
[TBL] [Abstract][Full Text] [Related]
40. Randomized Controlled Trials in Lung, Gastrointestinal, and Breast Cancers: An Overview of Global Research Activity.
Wells JC; Fundytus A; Sharma S; Hopman WM; Del Paggio JC; Gyawali B; Mukherji D; Hammad N; Pramesh CS; Aggarwal A; Sullivan R; Booth CM
Curr Oncol; 2022 Apr; 29(4):2530-2538. PubMed ID: 35448181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]